H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 123 Citations 66,905 684 World Ranking 1370 National Ranking 22

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Radiation therapy

His primary areas of study are Radiation therapy, Internal medicine, Oncology, Pathology and Surgery. Jens Overgaard has researched Radiation therapy in several fields, including Breast cancer, Carcinoma and Nuclear medicine. His study looks at the relationship between Breast cancer and fields such as Chemotherapy, as well as how they intersect with chemical problems.

His work in Internal medicine tackles topics such as Gastroenterology which are related to areas like Colorectal cancer and Adenoid cystic carcinoma. His work carried out in the field of Oncology brings together such families of science as Odds ratio, Cell, Clinical trial, Randomized controlled trial and Hazard ratio. Jens Overgaard has included themes like Cancer research, Radiosensitivity, Hypoxia, Hyperthermia and In vivo in his Pathology study.

His most cited work include:

  • Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy (2148 citations)
  • Postoperative radiotherapy in high-risk postmenopausal breast- cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial (1303 citations)
  • Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck (874 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Radiation therapy, Oncology, Pathology and Surgery. His work on Endocrinology expands to the thematically related Internal medicine. Jens Overgaard combines subjects such as Carcinoma, Randomized controlled trial and Nuclear medicine with his study of Radiation therapy.

The study incorporates disciplines such as Head and neck squamous-cell carcinoma, Head and neck, Basal cell, Hazard ratio and Cohort in addition to Oncology. His study looks at the intersection of Pathology and topics like In vivo with Mammary carcinoma. His Surgery study frequently draws connections to adjacent fields such as Urology.

He most often published in these fields:

  • Internal medicine (40.05%)
  • Radiation therapy (35.35%)
  • Oncology (30.55%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (40.05%)
  • Oncology (30.55%)
  • Radiation therapy (35.35%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Oncology, Radiation therapy, Head and neck cancer and DAHANCA. His study in Internal medicine concentrates on Cancer, Breast cancer, Cohort, Head and neck squamous-cell carcinoma and Nimorazole. His studies deal with areas such as Carcinoma, Clinical endpoint, Randomized controlled trial, Pathology and Hazard ratio as well as Oncology.

The Radiation therapy study combines topics in areas such as Clinical trial, Cohort study and Hypoxia. His DAHANCA study combines topics in areas such as Dose fractionation, Head and neck, Logistic regression and Quality assurance. His work on Prospective cohort study as part of his general Surgery study is frequently connected to In patient, thereby bridging the divide between different branches of science.

Between 2014 and 2021, his most popular works were:

  • Radiation oncology in the era of precision medicine (343 citations)
  • DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer (223 citations)
  • The impact of hypoxia and its modification of the outcome of radiotherapy. (125 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Radiation therapy

His primary scientific interests are in Internal medicine, Radiation therapy, Oncology, DAHANCA and Head and neck cancer. Much of his study explores Internal medicine relationship to Surgery. His biological study spans a wide range of topics, including Absolute risk reduction, Clinical trial, Medical physics and Carcinoma.

His Oncology study integrates concerns from other disciplines, such as Head and neck squamous-cell carcinoma, Pathology, Clinical endpoint, Hazard ratio and Breast cancer. His DAHANCA research is multidisciplinary, incorporating elements of Glottic Squamous Cell Carcinoma, Laryngectomy and Nimorazole. His Head and neck cancer research is multidisciplinary, incorporating perspectives in Prospective data, Larynx and Quality assurance.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy

Marie Overgaard;Per S. Hansen;Jens Overgaard;Carsten Rose.
The New England Journal of Medicine (1997)

2856 Citations

Postoperative radiotherapy in high-risk postmenopausal breast- cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

Marie Overgaard;Maj-Britt Jensen;Jens Overgaard;Per S Hansen.
The Lancet (1999)

1750 Citations

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

Marianne Nordsmark;Marie Overgaard;Jens Overgaard.
Radiotherapy and Oncology (1996)

1390 Citations

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

Jean Bourhis;Jens Overgaard;Helene Audry;Kian K. Ang.
The Lancet (2006)

1081 Citations

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

Marianne Nordsmark;Søren M. Bentzen;Volker Rudat;David Brizel.
Radiotherapy and Oncology (2005)

954 Citations

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

Jens Overgaard;Hanne Sand Hansen;Lena Specht;Marie Overgaard.
The Lancet (2003)

711 Citations

Hypoxic Radiosensitization: Adored and Ignored

Jens Overgaard.
Journal of Clinical Oncology (2007)

682 Citations

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85

Jens Overgaard;Hanne Sand Hansen;Marie Overgaard;Lars Bastholt.
Radiotherapy and Oncology (1998)

680 Citations

The current and potential role of hyperthermia in radiotherapy.

Jens Overgaard.
International Journal of Radiation Oncology Biology Physics (1989)

679 Citations

Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group

Marianne Kyndi;Flemming B. Sørensen;Helle Knudsen;Marie Overgaard.
Journal of Clinical Oncology (2008)

662 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Jens Overgaard

Søren M. Bentzen

Søren M. Bentzen

University of Maryland, Baltimore

Publications: 136

Philippe Lambin

Philippe Lambin

Maastricht University

Publications: 133

Mark W. Dewhirst

Mark W. Dewhirst

Duke University

Publications: 118

Catharine M L West

Catharine M L West

University of Manchester

Publications: 115

Thomas A. Buchholz

Thomas A. Buchholz

The University of Texas MD Anderson Cancer Center

Publications: 94

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 90

Richard P. Hill

Richard P. Hill

Princess Margaret Cancer Centre

Publications: 88

Bengt Glimelius

Bengt Glimelius

Uppsala University

Publications: 79

Johannes A. Langendijk

Johannes A. Langendijk

University Medical Center Groningen

Publications: 78

Brian O'Sullivan

Brian O'Sullivan

Princess Margaret Cancer Centre

Publications: 77

Bradly G. Wouters

Bradly G. Wouters

Princess Margaret Cancer Centre

Publications: 73

Harry Bartelink

Harry Bartelink

Antoni van Leeuwenhoek Hospital

Publications: 71

Roberto Orecchia

Roberto Orecchia

European Institute of Oncology

Publications: 63

Howard D. Thames

Howard D. Thames

The University of Texas MD Anderson Cancer Center

Publications: 62

Monica Morrow

Monica Morrow

Memorial Sloan Kettering Cancer Center

Publications: 62

Something went wrong. Please try again later.